Trial intelligence / Profile preview

Cyclopofol versus propofol-based sedation regimens for painless gastroscopy

ChiCTR2200066323Phase 4Not yet recruiting

Sponsor
Jiangxi Provincial People's Hospital
Start
Dec 2022
Modality
Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of ciprofol, propofol and etomidate in None (4 arms), sponsored by Jiangxi Provincial People's Hospital. Primary endpoints: Pain of injection, Dream and 1 more. Planned start Dec 2022; status: not yet recruiting.

02

Drugs

ciprofolpropofoletomidate

Beyond the preview

Go deeper on ChiCTR2200066323.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2200066323.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call